A. A licensee may prescribe, dispense and administer over-the-counter pharmaceuticals and topical prescription pharmaceuticals subject to the pharmaceutical agent classifications specified in section 32-1728.
B. Except as provided in subsection C of this section, a licensee may prescribe, dispense and administer the following oral prescription pharmaceuticals for the treatment of diseases of the eye and its adnexa for any one patient for each occurrence for a period of not more than the day limit recommended by the manufacturer or the physicians' desk reference, unless otherwise specified in this subsection, subject to the pharmaceutical agent classifications specified in section 32-1728:
1. Anti-infectives classified as tetracycline and its derivatives, cephalosporins, penicillin and its derivatives, macrolides, fluroquinolones and antivirals.
3. Nonsteroidal anti-inflammatory agents.
4. Agents for the treatment of angle-closure glaucoma, including carbonic anhydrase inhibitors.
5. Steroids in an amount that does not exceed the amount packaged for a single course of therapy of not more than seven days.
C. A licensee may not prescribe, dispense or administer an oral pharmaceutical specified in subsection B of this section or a controlled substance as specified in subsection D of this section to a person who is under six years of age.
D. A licensee may prescribe, dispense and administer a schedule III controlled substance only if it is an analgesic and any controlled substance only if it is an analgesic that is reclassified from schedule III to schedule II after January 1, 2014.
E. A licensee shall not prescribe, dispense or administer the following prescription substances:
1. An oral antifungal.
2. An oral antimetabolite.
3. An oral immunosuppressive.
4. A substance administered intravenously.
5. Except as provided in subsection F of this section, substances administered by injection.
6. Except as provided in subsection D of this section, a schedule I, II, IV or V controlled substance.
F. A licensee may use epinephrine auto-injectors to counteract an anaphylactic reaction.